- 3-12 months induction; years of maintenance
- Weeks to months depending on disease type and severity
- 86%
China versus the U.S.
- China clinical rate
- $1,000 – $8,000
- $4,500
- United States
- $15,000 – $50,000
- $32,500
- You save
- ~86%
- $28,000 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Specialized treatment of various glomerulonephritis subtypes including lupus nephritis, ANCA-associated vasculitis, and anti-GBM disease at China's leading nephrology departments. Treatment protocols follow international guidelines with access to biological agents, plasma exchange, and immunosuppressive combinations. High patient volumes ensure significant clinical expertise in managing these complex conditions.
Step by step.
Comprehensive Evaluation
Autoimmune serologies, complement levels, biopsy if needed, and systemic disease assessment
Induction Therapy
High-dose immunosuppression with cyclophosphamide, rituximab, or mycophenolate depending on subtype
Plasma Exchange if Indicated
Therapeutic plasmapheresis for rapidly progressive or anti-GBM disease presentations
Maintenance Therapy
Long-term immunosuppression with monitoring for relapse and treatment toxicity
- Expert management of rare glomerular diseases
- Access to rituximab and biologics at lower cost
- Plasma exchange capabilities at specialized centers
- Multidisciplinary approach for systemic autoimmune conditions
- Serious infections from immunosuppression
- Infertility risk with cyclophosphamide
- Malignancy risk with long-term immunosuppression
- Disease relapse requiring retreatment
Ask the AI for hospitals that handle glomerulonephritis treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.